Skip to main content
. Author manuscript; available in PMC: 2024 Mar 11.
Published in final edited form as: Am J Drug Alcohol Abuse. 2022 Jun 29;48(6):684–694. doi: 10.1080/00952990.2022.2083967

Table 3.

Lifetime use patterns, age of use initiation, past-year substance use, and substances that respondents endorsed as ranking among their top five most preferred substances (N = 129).

Lifetime prevalence and age of substance use initiation Past-year use Past-month use



N % M (SD) N % N %
Kratom 129 100.0% 29.9 (±8.81) 83 64.3% 59 45.7%
Alcohol 129 100.0% 15.0 (±3.28) 121 93.8% 104 80.6%
Combustible tobacco 123 95.3% 15.9 (±4.47) 82 63.6% 63 48.8%
Nonmedical cannabis 121 93.8% 16.8 (± 5.36) 93 72.1% 76 58.9%
Electronic cigarettes 105 81.4% 25.9 (±7.89) 68 52.7% 49 38.0%
Medically prescribed cannabis 103 79.8% 32.0 (±12.2) 14 10.9% 14 10.9%
Cannabidiol/CBD 103 79.8% 30.0 (±9.14) 70 54.3% 54 41.9%
Prescribed opioids 96 74.4% 20.4 (±6.42) 14 10.9% 7 5.4%
Nonmedical benzodiazepines 96 74.4% 21.0 (±7.80) 35 27.1% 24 18.6%
Nonmedical prescription opioids 91 70.5% 19.9 (±5.29) 41 31.8% 21 16.3%
Psychedelics 86 66.7% 19.9 (±5.62) 29 22.5% 12 9.3%
Powder cocaine 74 57.4% 20.4 (±4.76) 15 11.6% 3 2.3%
Ecstasy 73 56.6% 20.3 (±5.54) 14 10.9% 3 2.3%
Nonmedical prescription amphetamine 70 54.3% 21.3 (±7.31) 21 16.3% 11 8.5%
Medically prescribed benzodiazepines 66 51.2% 22.0 (±6.15) 25 19.4% 20 15.5%
Synthetic cannabinoids 53 41.1% 24.1 (±7.31) 1 0.8% 0 0.0%
Nonprescribed antipsychotics 46 35.7% 23.3 (±10.3) 10 7.8% 6 4.7%
Methamphetamine 44 34.1% 23.6 (±7.22) 10 7.8% 6 4.7%
Heroin 35 27.1% 24.8 (±7.08) 12 9.3% 6 4.7%
Crack cocaine 32 24.8% 21.8 (±6.55) 3 2.3% 1 0.8%
Nonmedical buprenorphine 31 24.0% 26.7 (±8.10) 9 7.0% 4 3.1%
Nonmedical prescription methadone 30 23.3% 26.1 (±6.71) 3 2.3% 1 0.8%
Dimethyltryptamine 26 20.2% 24.3 (±6.49) 3 2.3% 0 0.0%
Fentanyl 25 19.4% 27.8 (±6.68) 6 4.7% 3 2.3%
Nonprescribed antidepressants 25 19.4% 19.2 (±5.69) 4 3.1% 1 0.8%
Medically prescribed buprenorphine 14 10.9% 28.1 (±7.97) 6 4.7% 5 3.9%
Medically prescribed methadone 12 9.3% 26.9 (±4.56) 1 0.8% 1 0.8%
Modafinil 12 9.3% 25.9 (±6.28) 2 1.6% 1 0.8%
Synthetic cathinones 12 7.0% 26.9 (±6.30) 1 0.8% 0 0.0%
Tianeptine 6 4.7% 32.6 (±3.36) 3 2.3% 2 1.6%
Nonmedical androgenic anabolic steroids 5 3.9% 26.3 (±6.18) 0 0.0% 0 0.0%

Most preferred substances N %

Nonmedical cannabis 79 60.8%
Caffeine 67 51.5%
Kratom 63 48.5%
Alcohol 55 42.3%
Combustible tobacco 43 33.1%
Prescribed opioids 34 26.2%
Psychedelics 33 25.4%
Medically prescribed benzodiazepines 26 20.0%
Nonmedical prescription opioids 24 18.5%
Ecstasy 24 18.5%
Nonmedical benzodiazepines 22 16.9%
Cannabidiol/CBD 21 16.2%
Electronic cigarettes 21 16.2%
Nonmedical prescription amphetamine 21 16.2%
Powder cocaine 20 15.4%
Rx cannabis 16 12.3%
Heroin 13 10.0%
Street methamphetamine 12 9.2%
Antidepressants 9 6.9%
Crack cocaine 4 3.1%
Dimethyltryptamine 4 3.1%
Phenibut 4 3.1%
Synthetic cathinones 3 2.3%
Medically prescribed methadone 3 2.3%
Synthetic cannabinoids 2 1.5%
Fentanyl 2 1.5%
Nonmedical buprenorphine 1 0.8%
Nonmedical prescription methadone 1 0.8%
Tianeptine 1 0.8%
Modafinil 1 0.8%
Medically prescribed buprenorphine 0 0.0%